Bit Origin
BTOG
Strategy
MSTR
TeraWulf
WULF
BTCS Inc
BTCS
MARA Holdings
MARA
Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.